{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:01Z","timestamp":1792180741500,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.bbagen.2005.11.004","type":"journal-article","created":{"date-parts":[[2005,12,10]],"date-time":"2005-12-10T14:06:00Z","timestamp":1134223560000},"page":"547-559","source":"Crossref","is-referenced-by-count":32,"title":["Applied glycoproteomics\u2014approaches to study genetic-environmental collisions causing protein-losing enteropathy"],"prefix":"10.1016","volume":"1760","author":[{"given":"Lars","family":"Bode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudson H.","family":"Freeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2005.11.004_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0016-5085(72)80171-9","article-title":"Intestinal protein loss in Crohn's disease","volume":"62","author":"Beeken","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2005.11.004_bib2","first-page":"1","article-title":"Births: final data for 2002","volume":"52","author":"Martin","year":"2003","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.bbagen.2005.11.004_bib3","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0735-1097(02)01886-7","article-title":"The incidence of congenital heart disease","volume":"39","author":"Hoffman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-5223(98)70406-4","article-title":"Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group","volume":"115","author":"Mertens","year":"1998","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbagen.2005.11.004_bib5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1053\/euhj.1997.0777","article-title":"Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease","volume":"19","author":"Thorne","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbagen.2005.11.004_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/pcsu.2002.31498","article-title":"Strategies to treat protein-losing enteropathy","volume":"5","author":"Rychik","year":"2002","journal-title":"Semin. Thorac. Cardiovasc. Surg., Pediatr. Card. Surg. Annu."},{"key":"10.1016\/j.bbagen.2005.11.004_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00008480-200210000-00010","article-title":"Outcomes after the Fontan procedure","volume":"14","author":"Marino","year":"2002","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005176-200311000-00014","article-title":"Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified Fontan operations","volume":"37","author":"Fujii","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/cc2166","article-title":"Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?","volume":"7","author":"Lenz","year":"2003","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbagen.2005.11.004_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00005176-200310000-00019","article-title":"Enhanced production of interferon-gamma as a possible cause of protein-losing enteropathy after modified Fontan operation","volume":"37","author":"Shimizu","year":"2003","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"suppl. A","key":"10.1016\/j.bbagen.2005.11.004_bib11","doi-asserted-by":"crossref","first-page":"397A","DOI":"10.1016\/S0735-1097(04)91680-4","article-title":"Possible mechanisms for development of protein-losing enteropathy after Fontan operation","volume":"43","author":"Ostrow","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib12","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","article-title":"Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms","volume":"171","author":"Bruewer","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1348-0421.1999.tb02438.x","article-title":"Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNFalpha in inducing barrier dysfunction","volume":"43","author":"Chakravortty","year":"1999","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00075198-200304000-00011","article-title":"Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness","volume":"9","author":"Fink","year":"2003","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.bbagen.2005.11.004_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/gut.45.2.191","article-title":"Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function","volume":"45","author":"Fish","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2005.11.004_bib16","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1572-0241.2002.05914.x","article-title":"Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease","volume":"97","author":"Suenaert","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI113938","article-title":"Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers","volume":"83","author":"Madara","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2005.11.004_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.sbi.2005.08.010","article-title":"Altered glycan structures: the molecular basis of congenital disorders of glycosylation","volume":"15","author":"Freeze","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib19","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI2350","article-title":"Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy","volume":"101","author":"Niehues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2005.11.004_bib20","doi-asserted-by":"crossref","first-page":"129R","DOI":"10.1093\/glycob\/11.12.129R","article-title":"Update and perspectives on congenital disorders of glycosylation","volume":"11","author":"Freeze","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2005.11.004_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","article-title":"Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency","volume":"91","author":"Harms","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/mgme.2001.3161","article-title":"Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type ib: long-term outcome and effects of mannose supplementation","volume":"73","author":"Westphal","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbagen.2005.11.004_bib23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0002-9440(10)64830-4","article-title":"Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation","volume":"157","author":"Westphal","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005176-200403000-00010","article-title":"Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic","volume":"38","author":"Damen","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jmg.2003.016923","article-title":"Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency)","volume":"41","author":"Schollen","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbagen.2005.11.004_bib26","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1074\/jbc.M211950200","article-title":"A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation","volume":"278","author":"Chantret","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0140-6736(93)90485-Y","article-title":"Disruption of sulphated glycosaminoglycans in intestinal inflammation","volume":"341","author":"Murch","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.11.004_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.60.070191.002303","article-title":"Proteoglycans: structures and interactions","volume":"60","author":"Kjellen","year":"1991","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1083\/jcb.86.2.688","article-title":"Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion","volume":"86","author":"Kanwar","year":"1980","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.bbagen.2005.11.004_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1523-1755.2000.00858.x","article-title":"Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria","volume":"57","author":"Raats","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbagen.2005.11.004_bib31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(96)90941-1","article-title":"Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition","volume":"347","author":"Murch","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.11.004_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1092-9126(98)70005-5","article-title":"Management of protein-losing enteropathy after the Fontan procedure","volume":"1","author":"Rychik","year":"1998","journal-title":"Semin. Thorac. Cardiovasc. Surg., Pediatr. Card. Surg. Annu."},{"key":"10.1016\/j.bbagen.2005.11.004_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1399-3046.2001.005002135.x","article-title":"Reversal of protein-losing enteropathy in a child with Fontan circulation is correlated with central venous pressure after heart transplantation","volume":"5","author":"Holmgren","year":"2001","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.bbagen.2005.11.004_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00005176-199702000-00021","article-title":"Protein-losing enteropathy secondary to Fontan procedure resolved after cardiac transplantation","volume":"24","author":"Sierra","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4065\/73.8.777","article-title":"Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease","volume":"73","author":"Kelly","year":"1998","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbagen.2005.11.004_bib36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3476(97)70214-2","article-title":"Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation","volume":"130","author":"Donnelly","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbagen.2005.11.004_bib37","doi-asserted-by":"crossref","first-page":"G1028","DOI":"10.1152\/ajpgi.00066.2003","article-title":"Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways","volume":"285","author":"Neunlist","year":"2003","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib38","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.52.7.988","article-title":"Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC)","volume":"52","author":"Resta-Lenert","year":"2003","journal-title":"Gut"},{"issue":"Pt. 1","key":"10.1016\/j.bbagen.2005.11.004_bib39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1242\/jcs.112.1.137","article-title":"Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29\/B6","volume":"112","author":"Schmitz","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2005.11.004_bib40","first-page":"3370","article-title":"Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors","volume":"63","author":"Stoeltzing","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2005.11.004_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1097-0029(20000515)49:4<353::AID-JEMT4>3.0.CO;2-8","article-title":"Epithelial cell polarity as reflected in enterocytes","volume":"49","author":"Massey-Harroche","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.bbagen.2005.11.004_bib42","doi-asserted-by":"crossref","first-page":"G1015","DOI":"10.1152\/ajpgi.00461.2004","article-title":"Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy","volume":"288","author":"Bode","year":"2005","journal-title":"Am. J. Physiol.: Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcp.1041620114","article-title":"Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells","volume":"162","author":"Ramasamy","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib44","doi-asserted-by":"crossref","first-page":"40764","DOI":"10.1074\/jbc.M306736200","article-title":"Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration","volume":"278","author":"Endo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib45","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00173.2003","article-title":"TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation","volume":"286","author":"Ma","year":"2004","journal-title":"Am. J. Physiol.: Gasterointest. Liver Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev.physiol.60.1.121","article-title":"Molecular architecture of tight junctions","volume":"60","author":"Mitic","year":"1998","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1242\/jcs.113.11.2085","article-title":"Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma","volume":"113","author":"Mankertz","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2005.11.004_bib48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2005.11.004_bib49","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.gastro.2005.06.015","article-title":"Epithelial barrier function in vivo is sustained despite gaps in epithelial layers","volume":"129","author":"Watson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2005.11.004_bib50","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/labinvest.3700316","article-title":"Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells","volume":"85","author":"Prasad","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbagen.2005.11.004_bib51","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1016\/S0021-9258(19)57227-1","article-title":"Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma","volume":"261","author":"Tsujimoto","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib52","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.4049\/jimmunol.137.7.2272","article-title":"Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines","volume":"137","author":"Tsujimoto","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-9084(03)00078-6","article-title":"1976\u20131983, a critical period in the history of heparin: the discovery of the antithrombin binding site","volume":"85","author":"Petitou","year":"2003","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2005.11.004_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/PL00021007","article-title":"Protein-losing enteropathy","volume":"23","author":"Bendayan","year":"2002","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib55","first-page":"253","article-title":"Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity","volume":"37","author":"Lortat-Jacob","year":"1991","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0014-5793(91)80225-R","article-title":"Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule","volume":"280","author":"Lortat-Jacob","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2005.11.004_bib57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jcb.20068","article-title":"Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes","volume":"92","author":"Harvima","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib58","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1172\/JCI115530","article-title":"On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin","volume":"88","author":"Lantz","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2005.11.004_bib59","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1074\/jbc.273.18.10919","article-title":"The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation","volume":"273","author":"Sadir","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib60","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3100497","article-title":"Molecular organization of the interferon gamma-binding domain in heparan sulphate","volume":"310","author":"Lortat-Jacob","year":"1995","journal-title":"Biochem. J."},{"issue":"45","key":"10.1016\/j.bbagen.2005.11.004_bib61","doi-asserted-by":"crossref","first-page":"37558","DOI":"10.1074\/jbc.M507729200","article-title":"Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin-binding domain of IFNgamma inhibits the cytokine activity","volume":"280","author":"Sarrazin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib62","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-4165(02)00386-0","article-title":"Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase\/N-sulfotransferase isozymes","volume":"1573","author":"Grobe","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbagen.2005.11.004_bib63","doi-asserted-by":"crossref","first-page":"49175","DOI":"10.1074\/jbc.M205131200","article-title":"Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans","volume":"277","author":"Morimoto-Tomita","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib64","doi-asserted-by":"crossref","first-page":"29596","DOI":"10.1074\/jbc.M503691200","article-title":"A proteoglycan undergoes different modifications en route to the apical and basolateral surfaces of Madin\u2013Darby canine kidney cells","volume":"280","author":"Tveit","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib65","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1242\/jcs.00662","article-title":"Endothelial inflammation: the role of differential expression of N-deacetylase\/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate","volume":"116","author":"Carter","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbagen.2005.11.004_bib66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1042\/bst0310340","article-title":"Glucosaminyl N-deacetylase\/N-sulphotransferases in heparan sulphate biosynthesis and biology","volume":"31","author":"Kjellen","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2005.11.004_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/00365529509090262","article-title":"Growth factors: new \u2018endogenous drugs\u2019 for ulcer healing","volume":"210","author":"Szabo","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology\u2014Supplement"},{"key":"10.1016\/j.bbagen.2005.11.004_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(91)90173-V","article-title":"A dual receptor system is required for basic fibroblast growth factor activity","volume":"67","author":"Klagsbrun","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2005.11.004_bib69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","article-title":"Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor","volume":"64","author":"Yayon","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2005.11.004_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0140-6736(98)09267-8","article-title":"Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease","volume":"354","author":"Day","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2005.11.004_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jcp.40.1.61","article-title":"Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss","volume":"40","author":"Quigley","year":"1987","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.1.6058.428-a","article-title":"Simple method for diagnosing protein-losing enteropathies","volume":"1","author":"Crossley","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbagen.2005.11.004_bib73","first-page":"271","article-title":"Protein-losing enteropathy secondary to intestinal lymphangiectasia in a dog","volume":"173","author":"Olson","year":"1978","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.bbagen.2005.11.004_bib74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0016-5085(81)90012-3","article-title":"Protein-losing enteropathy in the human and experimental rat blind-loop syndrome","volume":"80","author":"King","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagen.2005.11.004_bib75","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0022-3468(91)90680-R","article-title":"Fecal fat, cyclosporine, and alpha 1-antitrypsin for assessment of small bowel function following transplantation","volume":"26","author":"Kitagawa","year":"1991","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.bbagen.2005.11.004_bib76","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI113245","article-title":"Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents","volume":"80","author":"Patton","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbagen.2005.11.004_bib77","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/dbio.2000.9798","article-title":"Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice","volume":"224","author":"Lin","year":"2000","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib78","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1126\/science.1090497","article-title":"Mammalian brain morphogenesis and midline axon guidance require heparan sulfate","volume":"302","author":"Inatani","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2005.11.004_bib79","doi-asserted-by":"crossref","first-page":"33275","DOI":"10.1074\/jbc.M204935200","article-title":"Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine","volume":"277","author":"Madison","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2005.11.004_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1096\/fj.03-0572com","article-title":"Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior","volume":"18","author":"Zcharia","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbagen.2005.11.004_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/77108","article-title":"Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice","volume":"25","author":"Alexander","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbagen.2005.11.004_bib82","first-page":"1135","article-title":"Role of syndecan-1 in leukocyte\u2013endothelial interactions in the ocular vasculature","volume":"43","author":"Gotte","year":"2002","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.bbagen.2005.11.004_bib83","doi-asserted-by":"crossref","unstructured":"C. Derossi, L. Bode, E.A Eklund, F. Zhang, J.A. Davis, V. Westphal, L. Wang, A. Borowsk, H.H. Freeze, Ablation of mouse phosphomannose isomerase (Mpi) causes mannose-6-phosphate accumulation, toxicity, and embryonic lethality, J. Biol. Chem. (in press).","DOI":"10.1074\/jbc.M511982200"},{"key":"10.1016\/j.bbagen.2005.11.004_bib84","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0300-9084(01)01292-5","article-title":"Balancing N-linked glycosylation to avoid disease","volume":"83","author":"Freeze","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.bbagen.2005.11.004_bib85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.physiol.59.1.575","article-title":"Tensegrity: the architectural basis of cellular mechanotransduction","volume":"59","author":"Ingber","year":"1997","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib86","first-page":"49","article-title":"Integrins, tensegrity, and mechanotransduction","volume":"10","author":"Ingber","year":"1997","journal-title":"Gravit. Space Biol. Bull.: Publ. Am. Soc. Gravit. Space Biol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib87","doi-asserted-by":"crossref","first-page":"L1078","DOI":"10.1152\/ajplung.2001.281.5.L1078","article-title":"Changes in proteoglycans and lung tissue mechanics during excessive mechanical ventilation in rats","volume":"281","author":"Al-Jamal","year":"2001","journal-title":"Am. J. Physiol., Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbagen.2005.11.004_bib88","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1291\/hypres.24.165","article-title":"Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats","volume":"24","author":"Sasamura","year":"2001","journal-title":"Hypertens. Res.-Clin. Exp."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416505003569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416505003569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:14:59Z","timestamp":1683321299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416505003569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0304416505003569"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2005.11.004","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}